Adam Geballe, M.D.

FACULTY MEMBER

Adam Geballe, M.D.

Member
Human Biology Division, Fred Hutch

Member
Clinical Research Division, Fred Hutch

Fax: 206.667.6523
Mailstop: C2-023

Dr. Adam Geballe studies the ongoing tug of war between virus and host. In particular, he focuses on cytomegalovirus, or CMV, a common, usually benign, infection. It can cause problems in people with suppressed immune function, such as bone marrow transplant recipients. As we have evolved molecular strategies to prevent infection, CMV has evolved ways to evade them. Dr. Geballe and his team pinpointed the two proteins that human CMV uses to evade the body’s defenses. Various types of CMV infect different organisms, from humans to guinea pigs to certain monkeys. Each has related proteins that allow it to sidestep our defensive strategies. Dr. Geballe aims to understand how these different proteins work and how they evolve. Ultimately, he hopes to better understand the viruses’ ability to counteract our defenses. His long-term goal is to be able to control the pathway to improve human health.

Other Appointments & Affiliations

Attending Physician, SCCA Infectious Disease Consulting Service
Seattle Cancer Care Alliance

Professor, Department of Medicine
University of Washington

Adjunct Professor, Department of Microbiology
University of Washington

Education

Duke University, 1978, M.D.

Research Interests

The Geballe Lab studies the functions and mechanisms of genes encoded by large DNA viruses, such as cytomegalovirus and vaccinia virus, that act to promote viral growth by blocking host cell defenses

Find a Clinical Trial

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email media@fredhutch.org or call 206.667.2210.